Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
Demonstrated or suggested benefit | Inconclusive results | Uncertain results | Safety results | |||
angiotensin converting enzyme inhibitors (ACEIs) | 0 | - | - | - | - | |
angiotensin receptor blockers (ARBs) | 0 | - | - | - | - | |
angiotensin-(1-7) | 0 | - | - | - | - | |
continuation of ACEI/ARB | 0 | - | - | - | - | |
discontinuation of ACEI/ARB | 0 | - | - | - | - | |
RAS blocker withdrawal | 0 | - | - | - | - | |
rhACE2 | 0 | - | - | - | - |